P

Inventor

SUN JEONGHOON

US39 patents
⚠️ This page may combine multiple inventors who share the name “SUN JEONGHOON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AMGEN INC

18 patents
US8034770B2Oct 11, 2011

FGF21 polypeptides comprising two or more mutations

AMGEN INC63 citations99
US8361963B2Jan 29, 2013

Uses of FGF21 polypeptides comprising two or more mutations

AMGEN INC64 citations98
US8999917B2Apr 7, 2015

Variant activin receptor polypeptides and uses thereof

AMGEN INC48 citations97
US7947646B2May 24, 2011

Variant activin receptor polypeptides

AMGEN INC66 citations97
US9809638B2Nov 7, 2017

Variant activin receptor

AMGEN INC25 citations94
US9273106B2Mar 1, 2016

FGF mutants with reduced proteolysis and aggregation

AMGEN INC9 citations92
US11072640B2Jul 27, 2021

Methods of treating non-alcoholic steatohepatitis using FGF21 mutants

AMGEN INC3 citations84
US10407487B2Sep 10, 2019

Variant activin receptor

AMGEN INC11 citations84
US10011642B2Jul 3, 2018

Methods of treating of diabetes and obesity using FGF21 mutants

AMGEN INC4 citations84
US9493530B2Nov 15, 2016

FGF21 mutants comprising a mutation at position 98, 171 and/or 180

AMGEN INC10 citations84
US9447165B2Sep 20, 2016

Variant activin IIB receptor

AMGEN INC11 citations84
US10308704B2Jun 4, 2019

Isolated nucleic acid molecules encoding stabilized receptor polypeptides and uses thereof

AMGEN INC12 citations83
US9610327B2Apr 4, 2017

Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof

AMGEN INC11 citations83
US9688756B2Jun 27, 2017

Variant Fc-polypeptides with enhanced binding to the neonatal Fc receptor

AMGEN INC3 citations68
US11840558B2Dec 12, 2023

Methods of treating non-alcoholic steatohepatitis using FGF21 mutants

AMGEN INC0 citations62
US11685770B2Jun 27, 2023

Stabilized receptor polypeptides and uses thereof

AMGEN INC0 citations62
US7981425B2Jul 19, 2011

Thrombopoietic compounds

AMGEN INC2 citations61
US10189890B2Jan 29, 2019

Variants of tissue inhibitor of metalloproteinase type three (TIMP-3), compositions and methods

AMGEN INC0 citations50

CELGENE CORP

7 patents

BELOUSKI EDWARD JOHN

6 patents

SUN JEONGHOON

3 patents

ALECTOR LLC

2 patents

AMGEN

1 patent

FACHINI ROGER

1 patent

MIN HOSUNG

1 patent